Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Simplified Insulin Protocol Using Lantus in ElderlyCompleted
NCT01480843Phase 4Updated Nov 8, 2017
Sponsor: Joslin Diabetes Center
Diabetes
United States
Study of Induction Docetaxel, Cisplatin and 5-FluorouracilTerminated
NCT00400205Phase 2Updated Nov 6, 2017
Sponsor: Emory University
Squamous Cell Carcinoma · Oral Cancer
United States
Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult SubjectsCompleted
NCT02591290Phase 4Updated Nov 6, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Japan
Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerCompleted
NCT02129257Phase 2Updated Oct 24, 2017
Sponsor: Hellenic Cooperative Oncology Group
Metastatic Colorectal Cancer
Greece
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompleted
NCT02260986Phase 3Updated Oct 17, 2017
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
United States, Australia, Canada, Czechia, Hungary +9 more
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)Completed
NCT01639040Phase 2Updated Oct 13, 2017
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
Germany, Hungary, Poland
TOFO Insulin Combination TrialCompleted
NCT02201004Phase 4Updated Oct 11, 2017
Sponsor: Sanofi
Type 2 Diabetes Mellitus
Japan
Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminated
NCT00833859Phase 2Updated Oct 9, 2017
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Pancreatic Neoplasms
United States
Salvage Radiation Therapy and Taxotere for PSA Failure After Radical ProstatectomyTerminated
NCT00480857Phase 2Updated Oct 6, 2017
Sponsor: University of Michigan Rogel Cancer Center
Prostate Cancer
United States
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical TrialCompleted
NCT01593228Phase 3Updated Sep 19, 2017
Sponsor: Sanofi
Solid Tumors
United States, Belgium, Italy, Spain
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.Terminated
NCT02833714N/AUpdated Sep 15, 2017
Sponsor: University of North Carolina, Chapel Hill
RELAPSING REMITTING MULTIPLE SCLEROSIS
United States
Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy AdultsCompleted
NCT00928785Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy
France, Germany
REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old ChildrenCompleted
NCT00447525Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Poliomyelitis
France
A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACompleted
NCT00693186Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Hepatitis B
Italy
Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXACompleted
NCT02012998Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Virus Diseases · Hepatitis B
Italy
Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECompleted
NCT01546909Phase 4Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Poliomyelitis
France
Safety of REPEVAX® Given One Month After REVAXIS®Completed
NCT00400309Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy Adult
France
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderCompleted
NCT01287949Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Poliomyelitis · Pertussis
France, Germany
Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish ChildrenCompleted
NCT01583049N/AUpdated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria, Tetanus and Pertussis
Spain
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationCompleted
NCT01839175Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Neisseria Meningitidis · Bacterial Infections · Virus Diseases
Finland
Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCompleted
NCT01249183Phase 3Updated Sep 11, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Pertussis · Poliomyelitis
France, Germany
Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersTerminated
NCT01217814Phase 2Updated Sep 1, 2017
Sponsor: Sanofi
Rheumatoid Arthritis
United States, Colombia, Czechia, Italy, Mexico +1 more
Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal CancerWithdrawn
NCT03264274Phase 2Updated Aug 31, 2017
Sponsor: Barts & The London NHS Trust
Colorectal Cancer
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresTerminated
NCT00832338Phase 2Updated Aug 31, 2017
Sponsor: Emory University
Breast Neoplasms · Breast Cancer · Cancer of the Breast
United States
The Immune Response to Influenza Vaccinations in Elderly IndividualsCompleted
NCT03266237Phase 4Updated Aug 30, 2017
Sponsor: National University Hospital, Singapore
Influenza
Singapore

Previous page Next page